July 23, 2015

Milbank Advises on Sale of Naturwohl Pharma to Perrigo

Share

Milbank represented the owners of Naturwohl Pharma GmbH on the sale of all shares to Perrigo, one of the world’s largest manufacturers of OTC-pharmaceutical products, headquartered in Ireland.

The product portfolio of Naturwohl includes Yokebe, the second largest dietary supplement brand in Germany which offers meal replacement products, e.g. in a shake or liquid form.

The transaction is still subject to approval by the cartel authorities. The transaction volume is confidential.

A Milbank team headed by Norbert Rieger and Andrea Eggenstein advised the owners of Naturwohl Pharma comprehensively on corporate, competition and tax law in relation to the transaction.

Advisor to the owners of Naturwohl Pharma GmbH: Milbank, Tweed, Hadley & McCloy LLP

Norbert Rieger (Corporate M&A, Munich), Andrea Eggenstein (Corporate/M&A, Frankfurt, joint lead), Matthias Schell (Tax, Munich), Alexander Rinne (Antitrust, Munich), Leopold Riedl (Corporate/M&A, Frankfurt), Nina Hornemann (both Corporate/M&A, Frankfurt), Timo Schwarzwälder (Corporate/M&A, Munich)

About Milbank

Milbank, Tweed, Hadley & McCloy LLP is a leading international law firm founded in 1866 in New York City. Today Milbank has offices in Beijing, Frankfurt, Hong Kong, London, Los Angeles, Munich, New York, São Paulo, Seoul, Singapore, Tokyo and Washington, DC and is present in all major financial and economic centers of the world. Milbank focuses its worldwide legal services in the areas of finance, transactions and litigation.

The first European office was opened in 1979 in London, followed by Frankfurt in 2001 and Munich in 2004. Due to the close cooperation of the German offices with the finance, corporate, cartel and tax lawyers practicing in other Milbank offices, in particular London and New York, Milbank Germany is in a position to provide fully integrated legal advice on the highest level in all these core areas pursuant to German, English and US law.